Publications by authors named "Karin Cerna"

Claim this Profile
C
Clinical significance of quantification and immunophenotyping of uterine NK cells in the diagnosis and treatment of infertility.
Karin Černá, Pavel Otevřel, Štěpánka Luxová, Lenka Sedláčková

Ceska Gynekol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced number of regulatory T cells in maternal circulation precede idiopathic spontaneous preterm labor in a subset of patients.
Michal Koucky, Zdenek Lastuvka, Helena Koprivova, Tereza Cindrova-Davies, Jiri Hrdy, Karin Cerna

Am J Obstet Gynecol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tofacitinib in Pregnancy: Assessing Pregnancy and Infant Outcomes, Cord Blood, and Breast Milk Concentrations.
Katarina Mitrova, Mette Julsgaard, Patrick Augustijns, Karin Cerna, Uma Mahadevan

Clin Gastroenterol Hepatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serological responses to vaccination in children exposed in utero to ustekinumab or vedolizumab: cross-sectional analysis of a prospective multicentre cohort.
Katarina Mitrova, Karin Cerna, Kristyna Zdychyncova, Barbora Pipek, Jana Svikova

Eur J Pediatr· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous infliximab in Crohn's disease patients with previous immunogenic failure of intravenous infliximab.
Julia Husman, Karin Černá, Katja Matthes, Maximilian Gilger, Maia Arsova

Int J Colorectal Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous Infliximab in Refractory Crohn's Disease Patients: A Possible Biobetter?
Karin Cerna, Dana Duricova, Martin Lukas, Martin Kolar, Nadezda Machkova

Crohns Colitis 360· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported symptoms are a more reliable predictor of the societal burden compared to established physician-reported activity indices in inflammatory bowel disease: a cross-sectional study.
Barbora Decker, Jan Tuzil, Milan Lukas, Karin Cerna, Martin Bortlik

Expert Rev Gastroenterol Hepatol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-SARS-CoV-2 Vaccination and Antibody Response in Patients With Inflammatory Bowel Disease on Immune-modifying Therapy: Prospective Single-Tertiary Study.
Karin Cerna, Dana Duricova, Martin Lukas, Nadezda Machkova, Veronika Hruba

Inflamm Bowel Dis· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular and Humoral Immune Responses to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease Patients.
Karin Cerna, Dana Duricova, Miroslav Hindos, Jana Hindos Hrebackova, Martin Lukas

J Crohns Colitis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis